Mark Adams, Ph.D.
Professor and Deputy Director, JAX Genomic Medicine
Leads the research and clinical genome sequencing groups.
As one of the founding scientists at TIGR, Dr. Adams contributed extensively to the first genome sequence of a free-living organism, Haemophilus influenzae, and other microbial genomes. A co-founder of Celera Genomics, he led the DNA sequencing and genome annotation groups. He directed the Drosophila, human, and mouse genome sequencing projects, and a large-scale re-sequencing program to identify novel SNPs in humans.
From 2003-2011, Dr. Adams was Associate Professor of Genetics at Case Western Reserve University where he developed a research program in the evolution and mechanisms of antibiotic resistance in the nosocomial pathogen Acinetobacter baumannii. He also served as Director of the Genomics Core facility.
From 2011-2016, Dr. Adams was the Scientific Director and Professor at the J. Craig Venter Institute. There he directed programs that characterized genomic changes in the evolution of antibiotic resistance in hospital-acquired infections.
Dr. Adams joined The Jackson Laboratory for Genomic Medicine in 2016, initially as director of Microbial Genomic Services. In 2020, he transitioned to lead a new R&D group for JAX’s clinical diagnostic laboratory. In 2023, he became the director of the Genome Technologies Scientific Service and leader of the CLIA-certified and CAP-accredited Advanced Precision Medicine Laboratory. Dr. Adams also serves as the deputy director for JAX Genomic Medicine. He received a B.A. in Chemistry from Warren Wilson College in Swannanoa, NC and a Ph.D. in Biological Chemistry from the University of Michigan.
-
Featured ArticleNovember 03, 2021Examining the Delta COVID-19 variant and more
What is the status of the SARS-CoV-2 variant Delta now? What other variants might emerge? And when can we finally move forward into the "new normal?" -
Featured ArticleJune 16, 2021Is the Microbiome the Key to Your Health
Experts in the microbiome research field gathered during a recent JAXtaposition event hosted by The Jackson Laboratory to discuss the trillions of microorganisms including bacteria, viruses, and fungi that live within us, and how they contribute to health and disease. -
Press ReleaseJanuary 26, 2021Continued public testing urged during vaccine rollout
While Connecticut's vaccine rollout is progressing successfully, with the state ranking fifth nationally for the highest percent of the population vaccinated, continued public testing and caution are still more important than ever.
-
Press ReleaseJune 21, 2021JAX center helps develop new genomic technology
JAX and principal investigator Mark Adams were chosen by the National Human Genome Research Institute to form the Technology Development Coordinating Center. The center will help accelerate genomics research through focused coordination and outreach programs. -
Press ReleaseJune 01, 2021JAX helps brief CT legislature on COVID-19 variants
Dr. Mark Adams of JAX and Dr. Nathan Grubaugh of the Yale School of Public Health spoke to legislators about how COVID s being monitored, which variants are present to date, and what we know about how the mutations are changing the properties of the virus itself. -
Press ReleaseJanuary 10, 2017Mark Adams joins The Jackson Laboratory as director, Microbial Genomic Services
Genomics pioneer and bioinformatics expert Mark Adams, Ph.D. will enhance the The Jackson Laboratory’s large-scale microbiome initiatives.